TAIKO PHARMACEUTICAL CO., LTD. (4574) Other
Market cap
¥15.4B
P/E ratio
27.8x
Makes over-the-counter medicines like Seirogan and Cleverin infection control products, serving consumers and institutions across Japan and Asia.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | 4.8 | 6 | 5.6 | 6.7 | 10.4 | 14.4 | -28.2 | -9.1 | -21.6 | 6.9 | 7.3 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 210 | 204 | 200 | 205 | 195 | 201 | 218 | 229 | 233 | 274 | 264 | 210 | 208 | 214 | 220 |
| Total payout ratio | - | - | - | 54.6 | 38.1 | - | - | 35.2 | 42.4 | 22 | - | - | -0 | 0.1 | - |